Navigation Links
Mens Sexual Prowess Not Affected by Prostate Cancer Drug

Men worried about taking finasteride, a drug proven effective in preventing prostate cancer, just because it might effect their performance in the bedroom, can now put their fears to rest, thanks to a new study.

The study, by researchers from the Southwest Oncology Group, found that though the drug does cause a drop in sexual function, the effects diminish over the course of time.

As a part of their study, the researchers surveyed more than 17,000 men 55 and older for seven years, and found that though men given finasteride reported on average more dysfunction than did men given a placebo, the small effect diminished over the seven years.

The study was led by Carol Moinpour, Ph.D., of the Fred Hutchison Cancer Research Center in Seattle.

The study grew out of the Prostate Cancer Prevention Trial, a large double-blind National Cancer Institute-funded study which found that finasteride, a drug which curbs the proliferation of prostate gland cells, is effective at preventing prostate cancer in men age 55 and older.

The 2003 results of that trial, conducted by the Southwest Oncology Group in more than 18,000 men, showed that finasteride could reduce a mans chances of getting prostate cancer by almost 25 percent.

In earlier studies, some men taking finasteride reported decreased libido, impotence and other signs of diminished sexual function. But researchers conducting the new study reported that the previous studies were studies were short-term and didnt try to assess the effects of age and other health factors, as well as individual variation.

The study authors used two surveys, a widely used Sexual Problems Scale and another questionnaire which they created, the Sexual Activity Scale. They also gathered other data to take into account other health factors that affect sexual function, such as age, medical conditions and smoking status. They surveyed the subjects three times in the first year and then annually for seven years.

Was this average decrease (in sexual function) an important difference? We concluded it was not, Moinpour said, adding that there were much larger differences due simply to individual variation among men in the trial.

The study suggests that finasteride will cause little or no sexual dysfunction for most men who decide to take it, conclude the authors.


'"/>




Related medicine news :

1. Sexual abuse affect health for a lifetime
2. Hypertensive Drug Improves Sexual Dysfunction in Hypertensive Men
3. Incidence Of Sexually Transmitted Diseases Among Gay Men On The Rise
4. Testosterone Patches Found To Increase Sexual Desire In Menopausal Women
5. Condom Vending Machines Increasing Sexual Assaults On Women
6. Sexually Abused Girls Develop Eating Disorders
7. Gynaecologist Faces Stiff Prison Sentence On Counts Of Sexual Abuse
8. New Sexual Misconduct Rule Against Doctors In The US
9. Historic Increase In Incidence Of Sexually Transmitted Diseases In Scotland
10. Youth Becoming Sexually Active At A Younger Age
11. Epilepsy Medicine May Result In Sexual Dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2016)... ... May 26, 2016 , ... ... a significant negative impact on long-term patient survival, reports a team of UPMC ... online this week in the Journal of Thoracic and Cardiovascular Surgery, provide critical ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... Retinal Degeneration” for the Foundation Fighting Blindness, Long Island Chapter on June 4, ... the public. , Dr. Maisel, founder of Retina Group of New York ...
(Date:5/26/2016)... ... May 26, 2016 , ... Leadership of Life ... announced the organization has earned its ISO 13485 certification, indicating the company’s quality ... all rules and policies associated with ISO quality standard 13485. , BSI ...
(Date:5/26/2016)... Rafael, CA (PRWEB) , ... May 26, 2016 ... ... will be offering campers a multitude of activities from daily practices, arts & ... self-confidence. , Camp Directors Amber East-D’Anna and Christy Evans have combined backgrounds in ...
(Date:5/26/2016)... ... May 26, 2016 , ... Power Systems, a leading ... PowerWave Instructor Certification Course in Stoughton, Massachusetts. The course was led by Power ... the 8 hour interactive course to qualify participants as certified PowerWave trainers. ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... , May 27, 2016 Amarantus ... focused on developing products for Regenerative Medicine, Neurology and Orphan Diseases, ... will be presenting at two upcoming investor conferences: ... 730 Third Avenue, New York City , NY ... Marcum MicroCap Conference   Where: Grand ...
(Date:5/26/2016)... 26, 2016 According to a new ... Market - U.S. Industry Analysis, Size, Share, Growth, Trends, and ... the U.S. was valued at US$ 5.89 Bn in 2014 ... from 2015 to 2023 to reach US$ 7.99 Bn in ... and emerging needle free drug delivery devices and the market ...
(Date:5/26/2016)... , May 26, 2016 ... With Both Cost Savings and Overall Decreased ... (LSE: BTG), an international specialist healthcare company, has ... the 21st Annual Meeting of ISPOR (International Society ... of hepatocellular carcinoma (HCC) using yttrium-90 glass microspheres ...
Breaking Medicine Technology: